Botanix Pharmaceuticals Ltd ABN 70 009 109 755 NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUM TO SHAREHOLDERS Date of Meeting Monday, 30 November 2026 Time of Meeting 9.30am (AWST) Place of Meeting At the offices of BDO, Level 9, Mia Yellagonga Tower 2, 5 Spring Street, Perth, Western...
Botanix Pharmaceuticals: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 30 pages · English
Summary by 6ix AI
This filing is a notice for the Annual General Meeting of Botanix Pharmaceuticals Limited, detailing the meeting's agenda and resolutions to be voted on by shareholders. The meeting is scheduled to take place at the offices of BDO in Perth, Australia, and includes resolutions regarding director re-elections and the adoption of the remuneration report. Shareholders are encouraged to review the accompanying explanatory memorandum for further details on the resolutions and voting procedures.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings CallRelease
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Application for quotation of securities - BOT
- Botanix Q1 FY27 Investor Update Webinar Presentation
- Botanix Quarterly Activities Report and Appendix 4C Q1 FY27
- Botanix Webinar on 27 October - Registration Information
- Initial Director's Interest Notice x2
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals